These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 840146)

  • 1. [Mode of action and control of "low dose heparin" (author's transl)].
    Bruhn HD; Albert JP; Petermann W
    Med Klin; 1977 Mar; 72(9):349-52. PubMed ID: 840146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Informative value of control methods for postoperative supervision of medication with aspirin and heparin (author's transl)].
    Schöndorf TH; Hey D
    MMW Munch Med Wochenschr; 1977 Jan; 119(4):119-22. PubMed ID: 402555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
    Despotis GJ; Joist JH
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The heparin-dependent inhibition of the accumulation of 131J-fibrinogen in the solid form of Walker-256-carcinosarcoma of the rat (author's transl)].
    Heyes H; Köhle W
    Arch Geschwulstforsch; 1978; 48(8):712-7. PubMed ID: 753192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of low-dose-heparin and its control (author's transl)].
    Zanoni G
    Schweiz Rundsch Med Prax; 1976 Apr; 65(16):477-80. PubMed ID: 981166
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombosis and thrombin].
    Hemker HC; Béguin S
    Ann Pharm Fr; 1992; 50(3):121-35. PubMed ID: 1290382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of heparin and thromboplastin on the half-life of 125I-protein C in the blood flow of rats].
    Kogan AE; Strukova SM
    Biull Eksp Biol Med; 1991 Feb; 111(2):116-8. PubMed ID: 1854945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Does low-dosage heparin treatment require serial haematological controls? (author's transl)].
    Bruhn HD; Albert JP; Sachs L; Timme H
    Dtsch Med Wochenschr; 1979 Sep; 104(38):1336-9. PubMed ID: 477560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated coagulation time test: a convenient monitor of heparinization for dogs used in cardiovascular research.
    Wilkerson RD; Conran PB; Greene SL
    Lab Anim Sci; 1984 Feb; 34(1):62-5. PubMed ID: 6716959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragmin (LMWH) vs heparin for anticoagulation during in vitro recycling of human blood in cardiopulmonary bypass circuits: dose-dependence and mechanisms of clotting.
    Bagge L; Holmer E; Wahlberg T; Nyström SO; Tydén H
    Blood Coagul Fibrinolysis; 1994 Apr; 5(2):273-80. PubMed ID: 8054461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of thrombin in plasma by heparin or arginine.
    Stief TW
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):146-53. PubMed ID: 17456623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of pulmonary embolism].
    Minar E
    Acta Med Austriaca; 1992; 19(1):25-34. PubMed ID: 1316706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo.
    Eichinger S; Wolz M; Nieszpaur-Los M; Schneider B; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1994 Dec; 72(6):831-5. PubMed ID: 7740450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin and platelet inhibition with low-dose calcium-heparin in comparison with ASA in patients with peripheral arterial occlusive disease at Leriche-Fontaine IIb class.
    Allegra C; Pollari G; Carioti B; Sardina M
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):646-51. PubMed ID: 7881702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heparin in therapeutics (author's transl)].
    Capel P
    Rev Med Brux; 1981 Mar; 2(3):181-9. PubMed ID: 7015442
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prophylaxis of thromboembolism using low dosage heparin (author's transl)].
    Frick U; Frick G
    Zentralbl Chir; 1979; 104(1):1-9. PubMed ID: 369234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anticoagulant capacity of plasmatic unfractionated heparin decreases at 23 degrees C.
    Stief TW
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):209-12. PubMed ID: 17287642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS; Murkin JM; Adams SJ
    Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A comparison of low dose heparin and oral anticoagulants in the prevention ot thrombo-phlebitis following gynaecological operations (author's transl)].
    Baertschi U; Schaer A; Bader P; Huber L; Morf P
    Geburtshilfe Frauenheilkd; 1975 Oct; 35(10):754-60. PubMed ID: 1183792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.